We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Veeva Systems (VEEV) Outperforms Broader Market: What You Need to Know
Read MoreHide Full Article
Veeva Systems (VEEV - Free Report) closed the most recent trading day at $280.68, moving +2.12% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.51% for the day. At the same time, the Dow added 0.93%, and the tech-heavy Nasdaq gained 0.48%.
Coming into today, shares of the provider of cloud-based software services for the life sciences industry had lost 2.58% in the past month. In that same time, the Medical sector lost 3.38%, while the S&P 500 gained 0.74%.
Market participants will be closely following the financial results of Veeva Systems in its upcoming release. It is anticipated that the company will report an EPS of $2.33, marking a 14.22% rise compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $933.79 million, up 15.11% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of $9.22 per share and a revenue of $3.69 billion, demonstrating changes of +13.83% and +15.35%, respectively, from the preceding year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Veeva Systems. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.78% higher. Veeva Systems is currently a Zacks Rank #3 (Hold).
Looking at valuation, Veeva Systems is presently trading at a Forward P/E ratio of 29.81. This indicates no noticeable deviation in contrast to its industry's Forward P/E of 29.81.
We can additionally observe that VEEV currently boasts a PEG ratio of 0.85. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical Info Systems industry currently had an average PEG ratio of 3.03 as of yesterday's close.
The Medical Info Systems industry is part of the Medical sector. This group has a Zacks Industry Rank of 84, putting it in the top 35% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Veeva Systems (VEEV) Outperforms Broader Market: What You Need to Know
Veeva Systems (VEEV - Free Report) closed the most recent trading day at $280.68, moving +2.12% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.51% for the day. At the same time, the Dow added 0.93%, and the tech-heavy Nasdaq gained 0.48%.
Coming into today, shares of the provider of cloud-based software services for the life sciences industry had lost 2.58% in the past month. In that same time, the Medical sector lost 3.38%, while the S&P 500 gained 0.74%.
Market participants will be closely following the financial results of Veeva Systems in its upcoming release. It is anticipated that the company will report an EPS of $2.33, marking a 14.22% rise compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $933.79 million, up 15.11% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of $9.22 per share and a revenue of $3.69 billion, demonstrating changes of +13.83% and +15.35%, respectively, from the preceding year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Veeva Systems. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.78% higher. Veeva Systems is currently a Zacks Rank #3 (Hold).
Looking at valuation, Veeva Systems is presently trading at a Forward P/E ratio of 29.81. This indicates no noticeable deviation in contrast to its industry's Forward P/E of 29.81.
We can additionally observe that VEEV currently boasts a PEG ratio of 0.85. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical Info Systems industry currently had an average PEG ratio of 3.03 as of yesterday's close.
The Medical Info Systems industry is part of the Medical sector. This group has a Zacks Industry Rank of 84, putting it in the top 35% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.